Get started
Author

Shreerang Sirdesai

A Ca v 3.2 T-Type Calcium Channel Point Mutation Has Splice-Variant-Specific Effects on Function and Segregates with Seizure Expression in a Polygenic Rat Model of Absence Epilepsy
2009 · Kim L. Powell, Stuart M. Cain, et al. · Journal of Neuroscience · 192
Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma
2020 · Shaji K. Kumar, Magdalini Migkou, et al. · Blood · 57
Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma
2018 · Sridurga Mithraprabhu, Shreerang Sirdesai, et al. · International Journal of Molecular Sciences · 40
PDF
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma
2024 · Meletios A. Dimopoulos, Magdalini Migkou, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16‐02 trial
2021 · Krystal Bergin, Flora Yuen, et al. · British Journal of Haematology · 6
A Cav3.2 T-type Calcium Channel Point Mutation Has Splice Variant-specific Effects on Function and Segregates With Seizure Expression in a Polygenic Rat Model of Absence Epilepsy
2008 · Caroline L. Ng, Kim L. Powell, et al. · Epilepsia · 6
A comparison between erythrocytapheresis and venesection for the treatment of JAK2 ‐mutated polycythaemia
2023 · Trung Q. Ngo, Matthew W. Scott, et al. · Internal Medicine Journal · 4
Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapy
2024 · Joshua W. D. Tobin, Venkata A. Chikatamarla, et al. · Blood Neoplasia · 2
The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival
2023 · Joshua W.D. Tobin, Rakin Chowdhury, et al. · Blood · 1
PDF
Development of RBC transfusion indications and the collection of patient‐specific pre‐transfusion information: summary
2017 · M. H. Yazer, L. van de Watering, et al. · Vox Sanguinis · 1
A novel mutation in the rat Ca(v)3.2 T-type Ca2 channel CACNA1H gene increases absence seizure expression
2007 · Kim L. Powell, Shreerang Sirdesai, et al. · Epilepsia · 1
Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre
2022 · Constantine S. Tam, Gareth P. Gregory, et al. · Internal Medicine Journal
Ps1381 a Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (itd) in Relapsed And/or Refractory Multiple Myeloma – the Amarc 16–02 Trial
2019 · K. Bergin, F. Yuen, et al. · HemaSphere
Pf604 the Australasian Leukaemia and Lymphoma (allg) Group Mm17 Trial: Response Adaptive Salvage With Carfilzomib‐thalidomide‐dexamethasone for Multiple Myeloma Patients Failing Front‐line Bortezomib
2019 · A. Spencer, H. Quach, et al. · HemaSphere
Transthyretin Val122Ile amyloidosis associated with isolated gastrointestinal disease and bowel rupture in a Caucasian woman
2019 · Shreerang Sirdesai, Patrick Hosking, et al. · Pathology
Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy
2018 · Andrew Spencer, Hang Quach, et al. · Blood
Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis
2018 · Krystal Bergin, Flora Yuen, et al. · Blood
A Genotype-Phenotype Correlation of Haemophilia a in Victorian Patients with a Description of Novel Mutations
2018 · Shreerang Sirdesai, Kerryn Weekes, et al. · Blood
Development of RBC transfusion indications and the collection of patient‐specific pre‐transfusion information
2017 · M. H. Yazer, L. van de Watering, et al. · Vox Sanguinis
Works count: 19
Citation count: 320
H-index: 6
I10-index: 4
Year
Topic
Type